Nuvalent, Inc.
Nuvalent, a biotech company specializing in oncology medicines, is seeking a Director of Medical Affairs Content and Training. The role involves leading development of scientific resources and training programs to support Medical Affairs field teams, ensuring scientific accuracy and compliance.
Headquarters
Cambridge, Massachusetts, United States
Company Size
11-50 employees
Founded
2017
Nuvalent, now a part of GSK following an acquisition completed in July 2026, is an oncology company that creates precisely targeted small-molecule therapies using deep expertise in chemistry and structure-based drug discovery. Its pipeline focuses on selective kinase inhibitors for genetically defined cancers, including ALK, ROS1, and HER2-driven solid tumors, with the goal of overcoming resistance and improving patient outcomes. The company has an approved therapy for locally advanced ROS1-positive non-small cell lung cancer, with lead programs including NVL-520, NVL-655, and NVL-330.
Nuvalent Appoints Ron Squarer to Board of Directors
Dec 10, 2025
American Century Companies Inc. Sells 11,767 Shares of Nuvalent, Inc. $NUVL
4 days ago
Nuvalent Outlines Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2025 Financial Results
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nuvalent, Inc..
Decoding Nuvalent Inc (NUVL): A Strategic SWOT Insight
2 weeks ago
Associate Director, Medical Affairs Content and Training
Revolution Medicines
Director, Medical Content and Training, Europe
Revolution Medicines
Associate Director, Medical Affairs Content and Training
Revolution Medicines
Director Medical Content and Training
Revolution Medicines
Director, Content Development
Acadia Pharmaceuticals Inc.
Director, International Scientific Content & Training
Madrigal Pharmaceuticals